#5: Bacteria and immunotherapy
An episode of the Inflammatory Content podcast, hosted by Kellen Cavagnero, Ph.D., titled "#5: Bacteria and immunotherapy" was published on February 29, 2020 and runs 14 minutes.
February 29, 2020 ·14m · Inflammatory Content
Summary
Engineering bacteria to kill cancer cells… Sounds like science fiction, right? Well, it’s actually all science, no fiction! Sreyan Chowdhury and colleagues from Tal Danino’s lab at Columbia University describe this novel therapeutic approach in their recent Nature Medicine publication, “Programmable bacteria induce durable tumor regression and systemic antitumor immunity”.Paper: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688650/Review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558487/Video: https://www.youtube.com/watch?v=fnpIIZrjMtM&t=18sTo help us spread science, please consider writing a review, sharing this episode with your friends and colleagues, or donating to support our work (Venmo @Kellen-Cavagnero). Please reach out to us via email ([email protected]) or Twitter (@KellenCavagnero) with any questions, comments, topic suggestions, etc.
Episode Description
Engineering bacteria to kill cancer cells… Sounds like science fiction, right? Well, it’s actually all science, no fiction! Sreyan Chowdhury and colleagues from Tal Danino’s lab at Columbia University describe this novel therapeutic approach in their recent Nature Medicine publication, “Programmable bacteria induce durable tumor regression and systemic antitumor immunity”.
Paper: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688650/
Review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558487/
Video: https://www.youtube.com/watch?v=fnpIIZrjMtM&t=18s
To help us spread science, please consider writing a review, sharing this episode with your friends and colleagues, or donating to support our work (Venmo @Kellen-Cavagnero).
Please reach out to us via email ([email protected]) or Twitter (@KellenCavagnero) with any questions, comments, topic suggestions, etc.
Similar Episodes
Apr 2, 2026 ·29m
Feb 5, 2026 ·37m
Sep 4, 2025 ·35m
Jul 30, 2025 ·53m